Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | GFER | P55789 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16604045 | 0.84 | KMT2A (0.44) | KMT2AGFERLMNAL3MBTL1SMN1; SMN2 | |
| SCHEMBL21701049 | 0.84 | ALDH1A1 (0.49) | KMT2ALMNAL3MBTL1MEN1MAPT | |
| SCHEMBL16604058 | 0.83 | ALDH1A1 (0.54) | KMT2AGFERLMNAL3MBTL1SMN1; SMN2 | |
| SCHEMBL47863 | 0.83 | KMT2A (0.49) | KMT2AGFERLMNAL3MBTL1SMN1; SMN2 | |
| SCHEMBL30587868 | 0.82 | KMT2A (0.52) | KMT2AGFERLMNAL3MBTL1SMN1; SMN2 | |
| SCHEMBL9455443 | 0.82 | KMT2A (0.52) | KMT2AGFERLMNAL3MBTL1SMN1; SMN2 | |
| SCHEMBL13310389 | 0.81 | LTA4H (0.50) | KMT2AGFERSMN1; SMN2MEN1MAPT | |
| SCHEMBL19341420 | 0.81 | HTT (0.47) | KMT2AGFERL3MBTL1SMN1; SMN2MEN1 | |
| SCHEMBL12792078 | 0.79 | KMT2A (0.45) | KMT2AGFERLMNAL3MBTL1SMN1; SMN2 | |
| SCHEMBL30933053 | 0.79 | ALDH1A1 (0.66) | KMT2AGFERSMN1; SMN2MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210284596-A1 | DIAMINE COMPOUND, METHOD FOR MANUFACTURING THE SAME, AND APPLICATIONS THEREOF | DAXIN MATERIALS CORP. (TW) | 2021-09-16 | — | — | US | disclosed |
| US-20160187776-A1 | COMPOUND FOR SEMICONDUCTOR PACKAGE, PHOTOSENSITIVE RESIN COMPOSITION INCLUDING THE SAME AND SEMICONDUCTOR PACKAGE STRUCTURE THEREOF | GTA ELECTRONICS CO., LTD (TW) | 2016-06-30 | — | — | US | disclosed |
| US-20160187776-A1 | COMPOUND FOR SEMICONDUCTOR PACKAGE, PHOTOSENSITIVE RESIN COMPOSITION INCLUDING THE SAME AND SEMICONDUCTOR PACKAGE STRUCTURE THEREOF | GTA ELECTRONICS CO., LTD (TW) | 2016-06-30 | — | — | US | disclosed |
| US-8133931-B2 | Acrylate nanocomposite material | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-03-13 | — | — | US | disclosed |
| US-8133931-B2 | Acrylate nanocomposite material | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-03-13 | — | — | US | disclosed |
| US-20100113638-A1 | Acrylate Nanocomposite Material | NATIONAL TAIWAN UNIVERSITY (TW) | 2010-05-06 | — | — | US | disclosed |
| US-20100113638-A1 | Acrylate Nanocomposite Material | NATIONAL TAIWAN UNIVERSITY (TW) | 2010-05-06 | — | — | US | disclosed |
| US-20080021193-A1 | Process of manufacturing DOPO derivatives for printed circuit board and low-earth orbit spacecraft applications | NATIONAL CHUNGHSING UNIVERSITY | 2008-01-24 | — | — | US | disclosed |
| US-20080021193-A1 | Process of manufacturing DOPO derivatives for printed circuit board and low-earth orbit spacecraft applications | NATIONAL CHUNGHSING UNIVERSITY | 2008-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210284596-A1 | DIAMINE COMPOUND, METHOD FOR MANUFACTURING THE SAME, AND APPLICATIONS THEREOF | AOC1, C9, PYM1 | KMT2A 661/4885GFER 2110/4885LMNA 710/4885 |
| US-20080021193-A1 | Process of manufacturing DOPO derivatives for printed circuit board and low-earth orbit spacecraft applications | DAO, DDT, PPOX | KMT2A 1855/4885GFER 340/4885LMNA 1191/4885 |
| US-20160187776-A1 | COMPOUND FOR SEMICONDUCTOR PACKAGE, PHOTOSENSITIVE RESIN COMPOSITION INCLUDING THE SAME AND SEMICONDUCTOR PACKAGE STRUCTURE THEREOF | SEM1, RER1, ASH2L | KMT2A 581/4885GFER 2425/4885LMNA 4128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.